|
ACR-368 Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: Prexasertib, prexasertib
Mobile, Alabama1 trial
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
University of South Alabama Mitchell Cancer Institute
Phase 2
Tampa, Florida1 trial
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
Moffitt Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.